A pragmatic approach to imaging in large vessel vasculitis

Bibliography

• Pipitone N, Salvarani C. Idiopathic aortitis: an underrecognized vasculitis. Arthritis Res Ther 2011;13(4):119
   Google Scholar
• Ogino H, Matsuda H, Minatoya K, et al. Overview of late outcome of medical and surgical treatment for Takayasu arteritis. Circulation 2008;118(25):2738-47
   PubMed Web of Science ®Google Scholar
• Bartels AL, Zeebregts CJ, Bijl M, et al. Fused FDG-PET and MRI imaging of Takayasu arteritis in vertebral arteries. Ann Nucl Med 2009;23(8):753-6
   Google Scholar
• Weaver FA, Kumar SR, Yellin AE, et al. Renal revascularization in Takayasu arteritis-induced renal artery stenosis. J Vasc Surg 2004;39(4):749-57
   PubMed Web of Science ®Google Scholar
• Salvarani C, Cimino L, Macchioni P, et al. Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis. Arthritis Rheum 2005;53(2):293-7
   PubMedGoogle Scholar
• Patil P, Karia N, Jain S, Dasgupta B. Giant cell arteritis: a review. Eye Brain 2013;5:23-33
   PubMedGoogle Scholar
• Nuenninghoff DM, Hunder GG, Christianson TJH, et al. Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum 2003;48(12):3522-31
   PubMedGoogle Scholar
• Evans JM, O’Fallon WM, Hunder GG. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study. Ann Intern Med 1995;122(7):502-7
   PubMed Web of Science ®Google Scholar
• Penn H, Dasgupta B. Giant cell arteritis. Autoimmun Rev 2003;2(4):199-203
   Google Scholar
• Daumas A, Bernard F, Rossi P, Granel B. “Extra-Cranial” Manifestations of Giant Cell Arteritis, Advances in the diagnosis and treatment of vasculitis. Amezcua-Guerra LM (Ed.), InTech Europe; Croatia: 2011. p. 291-310
   Google Scholar
• Kang T, Lanni S, Nam J, et al. The evolution of ultrasound in rheumatology. Ther Adv Musculoskelet Dis 2012;4(6):399-411
   Google Scholar
• Patil P, Dasgupta B. Role of diagnostic ultrasound in the assessment of musculoskeletal diseases. Ther Adv Musculoskelet Dis 2012;4(5):341-55
   Google Scholar
• Schmidt WA, Nerenheim A, Seipelt E, et al. Diagnosis of early Takayasu arteritis with sonography. Rheumatology (Oxford) 2002;41(5):496-502
   Google Scholar
• Schmidt WA, Blockmans D. Use of ultrasonography and positron emission tomography in the diagnosis and assessment of large-vessel vasculitis. Curr Opin Rheumatol 2005;17(1):9-15
   Google Scholar
• Schmidt WA, Wernicke D, Kiefer E, Gromnica-Ihle E. Colour duplex sonography of finger arteries in vasculitis and in systemic sclerosis. Ann Rheum Dis 2006;65(2):265-7
   Google Scholar
• Arida A, Kyprianou M, Kanakis M, Sfikakis PP. The diagnostic value of ultrasonography-derived edema of the temporal artery wall in giant cell arteritis: a second meta-analysis. BMC Musculoskelet Disord 2010;11:44
   PubMed Web of Science ®Google Scholar
• Suelves AM, España-Gregori E, Tembl J, et al. Doppler ultrasound and giant cell arteritis. Clin Ophthalmol 2010;4:1383-4
   Google Scholar
• Yamada I, Nakagawa T, Himeno Y, et al. Takayasu arteritis: evaluation of the thoracic aorta with CT angiography. Radiology 1998;209(1):103-9
   Google Scholar
• Restrepo CS, Ocazionez D, Suri R, Vargas D. Aortitis: imaging spectrum of the infectious and inflammatory conditions of the aorta. Radiographics 2011;31(2):435-51
   Google Scholar
• Park JH, Chung JW, Im JG, et al. Takayasu arteritis: evaluation of mural changes in the aorta and pulmonary artery with CT angiography. Radiology 1995;196(1):89-93
   PubMed Web of Science ®Google Scholar
• Khandelwal N, Kalra N, Garg MK, et al. Multidetector CT angiography in Takayasu arteritis. Eur J Radiol 2011;77(2):369-74
   Web of Science ®Google Scholar
• Blockmans D, Bley T, Schmidt W. Imaging for large-vessel vasculitis. Curr Opin Rheumatol 2009;21(1):19-28
   Google Scholar
• Bley TA, Uhl M, Carew J, et al. Diagnostic value of high-resolution MR imaging in giant cell arteritis. AJNR Am J Neuroradiol 2007;28(9):1722-7
   Google Scholar
• Bleeker-Rovers CP, Bredie SJH, van der Meer JWM, et al. F-18-fluorodeoxyglucose positron emission tomography in diagnosis and follow-up of patients with different types of vasculitis. Neth J Med 2003;61(10):323-9
   Google Scholar
• Bosnić D, Barešić M, Padjen I, et al. Fever of unknown origin: large vessel vasculitis diagnosed by PET/CT. Rheumatol Int 2013;33(9):2417-21
   Google Scholar
• Treglia G, Mattoli MV, Bertagna F, et al. Emerging role of Fluorine-18-fluorodeoxyglucose positron emission tomography in patients with retroperitoneal fibrosis: A systematic review. Rheumatol Int 2013;33(3):549-55
   Google Scholar
• Meller J, Strutz F, Siefker U, et al. Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI. Eur J Nucl Med Mol Imaging 2003;30(5):730-6
   Google Scholar
• Walter MA, Melzer RA, Schindler C, et al. The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl Med Mol Imaging 2005;32(6):674-81
   PubMed Web of Science ®Google Scholar
• Blockmans D, de Ceuninck L, Vanderschueren S, et al. Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum 2006;55(1):131-7
   PubMed Web of Science ®Google Scholar
• Blockmans D, Coudyzer W, Vanderschueren S, et al. Relationship between fluorodeoxyglucose uptake in the large vessels and late aortic diameter in giant cell arteritis. Rheumatology (Oxford) 2008;47(8):1179-84
   Web of Science ®Google Scholar
• Rabkin Z, Israel O, Keidar Z. Do hyperglycemia and diabetes affect the incidence of false-negative 18F-FDG PET/CT studies in patients evaluated for infection or inflammation and cancer? A Comparative analysis. J Nucl Med 2010;51(7):1015-20
   Google Scholar
• Zhuang HM, Cortés-Blanco A, Pourdehnad M, et al. Do high glucose levels have differential effect on FDG uptake in inflammatory and malignant disorders? Nucl Med Commun 2001;22(10):1123-8
   Google Scholar
• Ishimori T, Saga T, Mamede M, et al. Increased (18)F-FDG uptake in a model of inflammation: concanavalin A-mediated lymphocyte activation. J Nucl Med 2002;43(5):658-63
   Google Scholar
• Jones HA, Cadwallader KA, White JF, et al. Dissociation between respiratory burst activity and deoxyglucose uptake in human neutrophil granulocytes: implications for interpretation of (18)F-FDG PET images. J Nucl Med 2002;43(5):652-7
   PubMed Web of Science ®Google Scholar
• Iwabu M, Yamamoto Y, Dobashi H, et al. F-18 FDG PET findings of Takayasu arteritis before and after immunosuppressive therapy. Clin Nucl Med 2008;33(12):872-3
   Google Scholar
• Bleeker-Rovers CP, Bredie SJ, van der Meer JW, et al. Fluorine 18 fluorodeoxyglucose positron emission tomography in the diagnosis and follow-up of three patients with vasculitis. Am J Med 2004;116(1):50-3
   Google Scholar
• Fuchs M, Briel M, Daikeler T, et al. The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis. Eur J Nucl Med Mol Imaging 2012;39(2):344-53
   Google Scholar
• Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. The Lancet 2008;372(9634):234-45
   PubMed Web of Science ®Google Scholar
• Rojo-Leyva F, Ratliff NB, Cosgrove DM, Hoffman GS. Study of 52 patients with idiopathic aortitis from a cohort of 1,204 surgical cases. Arthritis Rheum 2000;43(4):901-7
   PubMedGoogle Scholar
• Ostberg G. An arteritis with special reference to polymyalgia arteritica. Acta Pathol Microbiol Scand Suppl 1973;237(Suppl 237):1-59
   Google Scholar
• Nordborg E, Bengtsson BA. Death rates and causes of death in 284 consecutive patients with giant cell arteritis confirmed by biopsy. BMJ 1989;299(6698):549-50
   Google Scholar
• Liu G, Shupak R, Chiu BK. Aortic dissection in giant-cell arteritis. Semin Arthritis Rheum 1995;25(3):160-71
   Google Scholar
• Schmidt WA, Seifert A, Gromnica-Ihle E, et al. Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis. Rheumatology (Oxford) 2008;47(1):96-101
   Web of Science ®Google Scholar
• Hamrin B, Jonsson N, Landberg T. Involvement Of Large Vessels In Polymyalgia Arteritica. Lancet 1965;1(7397):1193-6
   Google Scholar
• Hamrin B, Jonsson N, Landberg T. Arteritis In “Polymyalgia Rheumatica”. Lancet 1964;1(7330):397-401
   Google Scholar
• Blockmans D, Maes A, Stroobants S, et al. New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography. Rheumatology (Oxford) 1999;38(5):444-7
   Google Scholar
• Cimmino MA, Zampogna G, Parodi M. Is FDG-PET useful in the evaluation of steroid-resistant PMR patients? Rheumatology (Oxford) 2008;47(6):926-7
   Google Scholar
• Yamashita H, Kubota K, Takahashi Y, et al. Whole-body fluorodeoxyglucose positron emission tomography/computed tomography in patients with active polymyalgia rheumatica: evidence for distinctive bursitis and large-vessel vasculitis. Mod Rheumatol 2012;22(5):705-11
   PubMed Web of Science ®Google Scholar
• Patil P, Jain S, Achilleos K, et al. Prevalence, management and outcomes of pet positive large vessel vasculitis in difficult to treat PMR and GCA patients. Arthritis Rheum 2012;64(S10):S1-1216
   Google Scholar